Hopes Rise For SK’s COVID-19 Vaccine As It Moves To Comparative Phase III Trial
Korean Candidate A Global Contender?
Following positive interim Phase I/II results, expectations are rising for SK Bioscience’s recombinant COVID-19 vaccine as it becomes the first Korea-developed candidate to progress to Phase III.
